Short Communications 13
Schizophrenia and Pain - Preclinical

[SC13-1] Clinically predictive modulation of cognitive impairments in mouse touchscreen tasks

*Daisy Spark^1,2, Juulke Castelijn^1,2, Leonid Churilov³, Trang Pham^2,4, Michelle Camerino^2,4, Christopher J Langmead^2,5,6, Gregory D Stewart^2,5,6, Jess Nithianantharajah^1,2 (1. The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia, 2. Phrenix Therapeutics, Parkville, Victoria, Australia, 3. Melbourne Medical School, The University of Melbourne, Parkville, Victoria, Australia, 4. Australian Translational Medicinal Chemistry Facility, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, 5. Drug Discovery Biology, Neuroscience & Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, 6. Neuromedicines Discovery Centre, Monash University, Parkville, Victoria, Australia)

Keywords:Schizophrenia, Animal models, Drug discovery